ExLibris header image
SFX Logo
Title: Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Galli, G yr:2009


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Dormitzer, Philip R. "Influenza vaccine immunology." Immunological reviews 239.1 (2011): 167-177. Link to Full Text for this item Link to SFX for this item
2. Leroux-Roels, G. "Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial." Lancet, The 370.9587 (2007): 580-9. Link to SFX for this item
3. Rappuoli, R. "Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus." Science translational medicine 2.15 (2010): 15-15. Link to SFX for this item
4. Katz, J. M., J. "The public health impact of avian influenza viruses." Poultry science 88.4 (2009): 872-879. Link to SFX for this item
5. Yin, C. "Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial." The lancet 367.9523 (2006): 991-7. Link to SFX for this item
6. "[Effectiveness of flu vaccine in the prevention of severe cases. Season 2018-2019]." Gaceta sanitaria / 35.4: 339-344. Link to SFX for this item
7. Paules, Catharine I. "Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine." The New England journal of medicine. 378.1: 7-9. Link to SFX for this item
8. Nakayama, T. "[Influenza vaccine and adjuvant]." 薬学雑誌 131.12 (2011): 1723-31. Link to SFX for this item
9. anonymous. "Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines, March 2007." Relevé épidémiologique hebdomadaire 82.19 (2007): 164-167. Link to SFX for this item
10. Leroux-Roels, I. "An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults." The journal of infectious diseases 198.5 (2008): 642-9. Link to Full Text for this item Link to SFX for this item
11. Sambhara, S. "Breaking the immunogenicity barrier of bird flu vaccines." The lancet (2007): 544-5. Link to SFX for this item
12. Angeletti, D. "Understanding and Manipulating Viral Immunity: Antibody Immunodominance Enters Center Stage." Trends in immunology 39.7 (2018): 549-561. Link to SFX for this item
13. Alberini, I. "Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses." Vaccine 27.43 (2009): 5998-6003. Link to SFX for this item
14. Brammer, L.. "Update: Influenza Activity--United States, September 28--November 29, 2008." JAMA 301.4 (2009): 371-373. Link to SFX for this item
15. Stephenson, l. "Antigenically Distinct MF59-Adjuvanted Vaccine to Boost Immunity to H5N1." New England Journal of Medicine, The 359.15 (2008): 1631-1633. Link to SFX for this item
16. Ferguson, Neil M. "PUBLIC HEALTH: Enhanced: Public Health Risk from the Avian H5N1 Influenza Epidemic." Science 304.5673 (2004): 968-2196. Link to SFX for this item
17. Olsen, C. "DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza." Veterinary microbiology 74.1-2 (2000): 149-164. Link to Full Text for this item Link to SFX for this item
18. Govorkova, Elena A A. "Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004." Journal of virology 79.4 (2005): 2191-8. Link to Full Text for this item Link to SFX for this item
19. Hyman, G. "Transmission dynamics of the great influenza pandemic of 1918 in Geneva, Switzerland: Assessing the effects of hypothetical interventions." Journal of theoretical biology 241.2 (2006): 193-204. Link to SFX for this item
20. Ndongala, Y. "Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression." Clinical immunology 124.1 (2007): 57-68. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.